Claudio D'ambrosio PhD

Claudio is the CEO at Deallus Consulting, based in New York. During his consulting career he has served an array of clients and led multiple global projects dealing with the strategic enhancement of multi-billion dollar pharmaceutical brands.

Claudio has also advised senior management of mid to large life science companies on long term corporate strategies and advised on go no-go business case investments for products/franchises. He has driven the development of non-traditional ‘dynamic modeling’ capabilities at Deallus to help clients foresee the counterintuitive ‘cause & effects’ of their, or their competitors’, strategic decisions in the market place.

Claudio is well versed in facilitating competitive strategy simulations and he is a frequent speaker at Pharma conferences on topics such as business intelligence and strategy. Before leading North America, Claudio led the Deallus Oncology Practice, the largest and fastest growing business segment in the firm. In this role he has worked on many key oncology indications, characterised by a high degree of technological innovation.

Claudio possesses in-depth know-how of the regulatory, medical and commercial developments taking effect in the oncology and personalized healthcare fields. Prior to joining Deallus, Claudio worked as a researcher at the London Research Institute of Cancer Research UK, one of the Top Ten cancer research institutes worldwide. He obtained his PhD from LRI/UCL, London.

His PhD work on cancer research was published in top ranking peer-reviewed scientific journals. Prior to this, Claudio earned a degree in Biosciences and a Masters in the Business of Biotechnology.